Novavax Inc
Change company Symbol lookup
Select an option...
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc
Go

Health Care : Biotechnology | Mid Cap Value
Company profile

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Closing Price
$102.05
Day's Change
-4.99 (-4.66%)
Bid
--
Ask
--
B/A Size
--
Day's High
108.20
Day's Low
100.37
Volume
(Average)
Volume:
2,708,264

10-day average volume:
2,557,587
2,708,264

Okinawa Institute of Science and Technology Graduate University Deploys AMD EPYC(TM) Processors with Over 2 Petaflops of Computing Power Dedicated to Scientific Research

9:00 am ET October 1, 2020 (Globe Newswire) Print

-- AMD EPYC(TM) Processors provide superior cost-performance and high core density --

Today, AMD (NASDAQ: AMD) and Okinawa Institute of Science and Technology Graduate University (OIST) , announced the deployment of AMD EPYC(TM) 7702 processors for use in a new, high performance computing system. The EPYC processor-based supercomputer will deliver the 2.36 petaflops of computing power OIST plans to use for scientific research at the University.

The Scientific Computing & Data Analysis Section (SCDA) of OIST plans to implement the new supercomputer for supporting OIST computationally intensive research ranging from bioinformatics, computational neuroscience, and physics. SCDA adopted AMD EPYC after significant growth, including a 2X increase in users.

"2020 is a milestone year for OIST with new research units expanding the number of research areas. This growth is driving a significant increase in our computational needs," said Eddy Taillefer, Ph.D., Section Leader, Scientific Computing & Data Analysis Section. "Under the common resource model for which the computing system is shared by all OIST users we needed a significant increase in core-count capacity to both absorb these demands and cope with the significant growth of OIST. The latest AMD EPYC processor was the only technology that could match this core-count need in a cost-performance effective way."

Key factors of OIST's selection of the AMD EPYC processors included superior cost-performance, memory/PCIe(R) bandwidth, and high core counts per server. OIST plans to also consider EPYC processors for other growing computational needs for University researchers in the future.

"AMD is proud to be working with leading global institutions to bring scientific research to the forefront through the power of high performance computing technology," said Ram Peddibhotla, corporate vice president, EPYC product management, AMD. "With high performance capabilities, ease of management and scalability, 2 Gen AMD EPYC processors can assist OIST researchers with advancing technological innovations and supporting their research goals in bioinformatics, computational neuroscience, and physics."

AMD EPYC(TM) 7702 Processor Specifications

MODEL             CPU CORES THREADS MAX Boost Freq. (GHz) TDP (W) MAX DDR Freq. (1DPC) L3 CACHE (MB) PCIe
                                                                                                     Gen 4
                                                                                                     Lanes
AMD EPYC(TM) 7702 64        128     Up to 3.35            200     3200                 256           128

Supporting Resources

-- Learn more about AMD EPYC processors here

-- Learn more about AMD EPYC world records here

-- Become a fan of AMD on Facebook

-- Follow AMD on Twitter

About AMD

For 50 years AMD has driven innovation in high-performance computing, graphics, and visualization technologies â?? the building blocks for gaming, immersive platforms, and the datacenter. Hundreds of millions of consumers, leading Fortune 500 businesses and cutting-edge scientific research facilities around the world rely on AMD technology daily to improve how they live, work and play. AMD employees around the world are focused on building great products that push the boundaries of what is possible. For more information about how AMD is enabling today and inspiring tomorrow, visit the AMD (NASDAQ: AMD) website, blog, Facebook and Twitter pages.

Max boost for AMD EPYC processors is the maximum frequency achievable by any single core on the processor under normal operating conditions for server systems. EPYC-18

AMD, the AMD Arrow logo, EPYC, and combinations thereof, are trademarks of Advanced Micro Devices, Inc. Other names are for informational purposes only and may be trademarks of their respective owners.

Contact:

Gary Silcott

AMD Communications

(512) 602-0889

gary.silcott@amd.com

Laura Graves

AMD Investor Relations

(408) 749-5467

laura.graves@amd.com

https://ml.globenewswire.com/media/9782a337-07ac-424b-9c5a-f9cde47d8d55/small/amd-logo-black-jpg.jpg

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.